GlaxoSmithKlinePositions on U.S. Legislation

GlaxoSmithKline took positions on (supported or opposed) 6 bills in the U.S. Congress from Jan. 1, 2007 to May 6, 2012.

1 Bill: H.R. 3261 (112th Congress) Sponsor: Rep. Lamar Smith (R, TX-21)Stop Online Piracy Act

Summary: To promote prosperity, creativity, entrepreneurship, and innovation by combating the theft of U.S.property, and for other purposes.

Status: The bill has been introduced.

Position: SupportedDate of position: Dec. 14, 2011Source: Letters and Testimonies; To the Members of the United States Congress (link)Retrieved: Jan. 26, 2012Source attached as: Appendix A -- page 3

2 Bill: H.R. 1249 (112th Congress) Sponsor: Rep. Lamar Smith (R, TX-21)Leahy-Smith America Invents Act

Summary: To amend title 35, United States Code, to provide for patent reform. Status: The bill has become law.

Position: SupportedDate of position: June 21, 2011Source: Press Releases; The Coalition for 21st Century Patent Reform reaffirms its support for moving H.R.

1249. (link)Retrieved: May 1, 2012Source attached as: Appendix B -- page 14

3 Bill: S. 606 (112th Congress) Sponsor: Sen. Robert Casey (D, PA)Creating Hope Act of 2011

Summary: A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the priority review voucherincentive program relating to tropical and rare pediatric diseases.

Status: The bill has been introduced.

Position: SupportedDate of position: March 17, 2011Source: Robert P. Casey, Jr. United States Senator for Pennsylvania; Casey Introduces Bipartisan Bill to Help

Develop Treatments for Rare Diseases (link)Retrieved: July 15, 2011Source attached as: Appendix C -- page 16

Page 1

4 Bill: S. 23 (112th Congress) Sponsor: Sen. Patrick Leahy (D, VT)America Invents Act

Summary: A bill to amend title 35, United States Code, to provide for patent reform. Status: The bill was voted on in the Senate on March 8, 2011.

Position: SupportedDate of position: March 8, 2011Source: Press Releases; Senate panel backs patent overhaul bill (link)Retrieved: June 22, 2011Source attached as: Appendix D -- page 19

5 Bill: H.R. 3080 (112th Congress) Sponsor: Rep. Eric Cantor (R, VA-7)United States-Korea Free Trade Agreement Implementation Act

Summary: To implement the United States-Korea Free Trade Agreement. Status: The bill has become law.

Position: SupportedDate of position: Jan. 5, 2011Source: US Chamber of Commerce; Letter to Members of the 112th Congress (link)Retrieved: May 2, 2012

6 Bill: S. 515 (111th Congress) Sponsor: Sen. Patrick Leahy (D, VT)Patent Reform Act of 2009

Summary: A bill to amend title 35, United States Code, to provide for patent reform. Status: The bill has passed through committee and has been put on a legislative calendar.

Position: SupportedDate of position: April 2, 2009Source: Press Releases; Coalition Supports Patent Reform Legislation Adopted in Senate Judiciary Committee

(link)Retrieved: May 2, 2012Source attached as: Appendix E -- page 20

Data source:

Support and opposition information is based on public documents found by MapLight, including congressional testimony, news reports,and company statements. This report of positions taken on legislation should not be considered comprehensive, as there may beadditional legislation GlaxoSmithKline supports or opposes that MapLight research did not reveal. Report generated May 7, 2012.Copyright © 2012 MapLight. All rights reserved.

Page 2

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 3

December 14, 2011

TO THE MEMBERS OF THE UNITED STATES CONGRESS:

The undersigned businesses, trade associations, and professional and labor organizations,representing a broad cross-section of the American economy, write in support of rogue siteslegislation. We commend both the House and the Senate for their attention to this importantissue.

We urge Congress to enact legislation that targets those who abuse the Internet ecosystem andreap illegal profits by stealing the intellectual property (IP) of America’s innovative and creativeindustries. These rogue sites—websites dedicated to counterfeiting and piracy—put Americanjobs, consumers, and innovation at risk.

Using the veil of sophisticated and well-designed websites, many of these online IP thieves poseas legitimate businesses, luring consumers to purchase fraudulent products. Some rogue siteseven sell dangerous and defective goods that jeopardize the health and safety of Americanconsumers who are deceived into purchasing consumer goods that are poorly constructed or evencontaminated with dangerous toxins. Consumers also unwittingly put themselves at risk ofidentity theft and malicious computer viruses by visiting these sites.

IP-intensive industries are a cornerstone of the U.S. economy, employing more than 19 millionpeople and accounting for 60 percent of exports. Rampant online counterfeiting and piracypresents a clear and present threat to American jobs and innovation. A study examinedapproximately 100 rogue sites and found that these sites attracted more than 53 billion visits peryear, which averages out to approximately nine visits for every man, woman, and child on Earth.Global sales of counterfeit goods via the Internet from illegitimate retailers reached $135 billionin 2010. The theft of American IP is the theft of American jobs.

The United States cannot and should not tolerate this criminal activity. Not only are jobs andconsumers at risk, but rogue sites contribute absolutely no value to the U.S. marketplace. Theoperators of rogue sites break laws, do not pay taxes, and skirt accountability. In light of theseconcerns, we urge you to enact carefully balanced rogue sites legislation this year. We commendthe House and the Senate for their attention to this important issue and look forward to workingwith you in support of that goal.

Sincerely,

1-800 Contacts, Inc.

1-800-PetMeds

1K Studios

2b1 Inc

3M Company

ABRO Industries, Inc.

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 4

Acushnet Company

adidas America

Advanced Medical Technology Association (AdvaMed)

Allen Russell Photography

Alliance of Automobile Manufacturers

Alliance of Visual Artists (AVA)

Altria Client Services

American Apparel and Footwear Association

American Association of Independent Music (A2IM)

American Board of Internal Medicine

American Federation of Musicians

American Gramaphone LLC

American Made Alliance

American Mental Health Counselors Association

American Photographic Artists

American Society of Composers, Authors and Publishers (ASCAP)

American Society of Media Photographers

American Society of Picture Professionals

American Watch Association

Anatoly Pronin Photography

Andrea Rugg Photography

Anti-Counterfeiting and Piracy Initiative (ACAPI)

Applied DNA Sciences

Art Holeman Photography

Association of American Publishers (AAP)

Association of Equipment Manufacturers

Association of Independent Music Publishers (AIMP)

Association of Test Publishers

AstraZeneca plc

Australian Medical Council

Autodesk, Inc.

Automotive Aftermarket Industry Association

Baker & Taylor Ent.

Bay State Psychological Associates

Beachbody, LLC

Beam Global Spirits & Wine

Benchmade Knife Company

Bill Parker Studios Inc.

Blue Sky Studios, Inc.

Bose Corporation

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 5

Braasch Biotech LLC

Brian Stevenson Photography

Brigid Collins Family Support Center

Broadcast Music, Inc. (BMI)

Build Media, Inc.

Burberry

Burning House Records

Burton Snowboards

C. F. Martin & Co., Inc.

Callaway Golf Company

Canada Goose

Cascade Designs Incorporated

Caterpillar Inc.

Caveon, LLC

CBS Corporation

Cengage Learning

Center for Credentialing & Education

Center Stage Photography

CFA Institute

Chanel USA

Christopher Semmes Photography

Chrysler Group LLC

Church Music Publishers Association

Cimarron Group

CMH Images

Coach

Coalition Against Counterfeiting and Piracy (CACP)

Columbia Sportswear Company

Comcast Corporation

Commercial Photo Design

Commercial Photographers International

Comprehensive Adult Student Assessment System

Consumer Healthcare Products Association

Copyright Alliance

Copyright Clearance Center (CCC)

Coty Inc.

Council of Fashion Designers of America

Country Music Association

Creative America Campaign Inc.

Creative Microsystems Corporation

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 6

CropLife America

Cross-Entertainment LLC

CSA Group

CVS Caremark

D'Addario & Company, Inc.

Dan Sherwood Photography

Danita Delimont Stock Photography

Dayco Products, LLC

Deluxe Entertainment Services Group

Dennyfoto

Derek DiLuzio Photography

DeVaul Photography

Diffraction LTD

Direct Selling Association (DSA)

Directional Insight

DIRECTV

Distefano Enterprises Inc.

Dolby Laboratories, Inc.

Dolce & Gabbana USA, INC.

Dollar General Corporation

Don Grall Photography

Doriguzzi Photographic Artistry

Dunford Architectural Photography

Eagle Rock Entertainment

Economic Strategy Group

Ed McDonald Photography

Educational & Industrial Testing Service

Electronic Arts, Inc.

Electronic Components Industry Association (ECIA)

Electronic Retailing Association

Eli Lilly and Company

Englebert Photography

Entertainment Software Association (ESA)

ERAI, Inc.

Eric Meola Studio Inc

ESPN Inc.

Evidence Photographers International Council

Ex Officio

Exxel Outdoors

FAME Publishing Co., LLC.

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 7

FAME Recording Studios

Far Bank Enterprises

Fashion Business Incorporated

Federation of State Boards of Physical Therapy

Fender Musical Instrument Company

FilmL.A., Inc.

Five By Five Inc.

Footwear Distributors & Retailers of America (FDRA)

Ford Motor Company

Fortune Brands, Inc.

Fred J. Lord Photography

GAR Associates

Gelderland Productions, L.L.C.

Gemvision Corporation

Gibson Guitar Corp.

GlaxoSmithKline

Gospel Music Association

Governors America Corp.

Graduate Management Admission Council

Graphic Artists Guild

Greeting Card Association (GCA)

Greg Nikas Photography

Gucci America, Inc.

Guru Denim

H.S. Marketing & Design, Inc.

Harley-Davidson Motor Company

HarperCollins Publishers

Harry Fox Agency

Hastings Entertainment, Inc.

ICM Distributing Company, Inc.

IDS Publishing

IEC Electronics corp.

Images Plus

Imaging Supplies Coalition (ISC)

IMAX Corporation

Independent Distributors of Electronics Association (IDEA)

INgrooves

Innate-gear

InterContinental Hotels Group (IHG)

International AntiCounterfeiting Coalition (IACC)

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 8

International Trademark Association (INTA)

IPC-Association Connecting Electronics Industries

IPCybercrime.com LLC

Ira Montgomery Photography

J.S. Grove Photography

James Drug Inc.

Jaynes Gallery

JCPage Photography

Jean Poland Photography

Jeff Stevensen Photography

John Fulton Photography

John Wiley & Sons, Inc.

Johnson & Johnson

Juicy Couture, Inc

Julien McRoberts Photography

K&R Photographics

kate spade

Kekepana International Services

Kenneth Garrett, photographer for National Geographic

Killing Jar Productions LLC

Lacoste USA

Laurent Bouzereau, producer for Nedland Media, Inc.

Leatherman Tool Group, Inc.

Lexmark International, Inc.

Lieberman Research Worldwide

Light Perspectives

Linda Olsen Photography

Little Dog Records

Liz Claiborne, Inc

L'Oréal USA

Lucky Brand Jeans

LVMH Moët Hennessy Louis Vuitton

Macmillan

Major League Baseball

Major League Soccer

Marcia Andberg Associates LLC

Mark Niederman Photography

Marmot

Marona Photography

McLain Photography Inc

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 9

Merck & Co., Inc.

Messy Face Designs, Inc.

Michael Stern Photography

MicroRam Electronics, Inc.

Minor League Baseball

Minter Works of Art

Mira Images

Mob Scene Creative Productions

Monster Cable Products, Inc.

Moose’s Photos

Morningstar Films LLC

Motion Picture Association of America, Inc. (MPAA)

MotionMasters

Motor & Equipment Manufacturers Association

MPA - The Association of Magazine Media

Mr. Theodor Feibel (sole proprietor)

Music Managers Forum-U.S.

Nashville Songwriters Association International

Natalie Neckyfarow Actor/Dancer/Singer

National Association of Broadcasters

National Association of Manufacturers

National Association of Music Merchants

National Association of Recording Merchandisers (NARM)

National Association of Theatre Owners (NATO)

National Basketball Association (NBA)

National Board for Certified Counselors

National Board for Certified Counselors Foundation

National Confectioners Association

National Electrical Manufacturers Association (NEMA)

National Football League (NFL)

National Music Publishers' Association (NMPA)

National Retail Federation (NRF)

NBCUniversal

Nervous Tattoo Inc., dba Ed Hardy

New Balance Athletic Shoe, Inc.

New Era Cap Co Inc

New Levels Ent. Co. LLC

News Corporation

Next Decade Entertainment, Inc.

NHL Enterprises, L.P.

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 10

Nicholas Petrucci, Artist, LLC

Nike, Inc.

Nintendo of America Inc.

Nissle Fine Art Photography

North Dakota Pharmacists Association

North Dakota Pharmacy Service Corporation

Oakley, Inc.

One Voice Recordings

OpSec Security, Inc.

Outdoor Industry Association

Outdoor Power Equipment Institute (OPEI)

Outdoor Research, Inc

Pacific Component Xchange, Inc.

Party Killer Films LLC

Pearson Clinical Assessment

Peavey Electronics Corporation

Perry Ellis International

Personal Care Products Council

Peter C. Brandt, Architectural and Fine Art Photography

Peter Hawkins Photography, Inc.

Petzl America

Pfizer Inc.

PGA of America

Philip Morris International

Photojournalist Dave Bartruff

Picture Archive Council of America (PACA)

Pigfactory Music

PING

PNW Images

Premier League

Production Music Association (PMA)

Professional Photographers of America

Quality Float Works, Inc.

Raging Waters Music

Ralph Lauren Corporation

Ramsay Corporation

Rebel Photo

Recording Industry Association of America (RIAA)

Red Wing Shoe Company

Red4 Music/Doogs Rock Inc

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 11

Reebok International Ltd.

Reed Elsevier Inc.

Renie Design

Retail Industry Leaders Association (RILA)

Reverb Productions

Revlon

Richard Flutie Photography

Rite Aid

Robin Davis Photography, Inc.

Rodger Scott Craig, a member of Liverpool Express, The Merseybeats, Fortune, Harlan Cage,

101 South, and Mtunz Media

Roger Smith Photography Services

Rolex Watch USA Inc.

Romance Writers of America (RWA)

Romin, Inc.

Rosenthal Consulting LLC

Rosetta Stone Inc.

Saddle Creek

Sage Studios LLC

Sam D'Amico Photography

Schneider Electric

Sean McGinty Photography

Secret Sea Visions (Photography)

SESAC, Inc.

SG Industries, Inc.

Shure Incorporated

SIGMA Assessment Systems

Six Degrees Records

Small Business & Entrepreneurship Council

SMC Entertainment

SMT Corp.

SoBe Entertainment

Soccer United Marketing

Society of Sport & Event Photographers

Software & Information Industry Association (SIIA)

Sony Electronics Inc.

Sony Music Entertainment

Sony Pictures Entertainment

Soul Appeal Records and Music

SoundExchange

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 12

Southern Gothic LLC

Specialty Equipment Market Association (SEMA)

SPI (The Plastics Industry Trade Association)

Sporting Goods Manufacturers Association

Sports Rights Owners Coalition

Spring Fever Productions LLC

Spyder Active Sports, Inc

Stenbakken Photography

Stephen Dantzig Photography

Stock Artists Alliance

Stuart Weitzman Holdings, LLC

Student Photographic Society

Studio 404

SunRise Solar Inc.

Taylor Glenn Photographs

Taylor Guitars

Taylor Made Golf Company, Inc.

Technicolor

Tednologies, Inc.

The Cambridge Don

The Collegiate Licensing Company/IMG College

The Donath Group, Inc.

The Dow Chemical Company

The DVD Cafe'

The EMI Group

The Estee Lauder Companies

The McGraw-Hill Companies

The Music People! Inc.

The National Collegiate Athletic Association (NCAA)

The Nielsen Co.

The Recording Academy (National Academy of Recording Arts and Sciences)

The Timberland Company

The Walt Disney Company

Tiffany & Co.

Tighe Creative Solutions, Inc.

Time Warner Inc.

Tony Bullard Photography

Toshiba America Business Solutions, Inc.

TRA Global

Trailer Park

APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 13

Tricoast Worldwide

Trio Productions, Inc. / Songscape Music,

Twist & Shout, Inc.

U.S. Chamber of Commerce

Ultimate Fighting Championship

Under Armour

Underwriters Laboratories Inc.

United States Tennis Association

Universal Music Group

Uniweld Products Inc.

VF Corporation

Viacom

Vibram USA, Inc

Victorinox Swiss Army, Inc.

Virtual Chip Exchange USA, Inc.

Voltage Pictures, LLC

W.R. Case & Sons Cutlery Co.

Walcott Studio, LLC

Wal-Mart

Warner Music Group

Wendy Kaveney Photography

Western Psychological Services

Westmorland Images, LLC

Wild & Associates, Inc.

Wild Eye Photos LLC

William Sutton Photography

Willis Music

WindLegends Ink LLC

Winestem Company

Winslow Research Institute

Wolfe Video

Wolverine World Wide, Inc.

Woolrich, Inc.

World Wrestling Entertainment, Inc.

Xerox Corporation

Zippo Manufacturing Company

Zumba Fitness, LLC

APPENDIX B GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 14

APPENDIX B GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 15

APPENDIX C GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 16

Printer-friendly

Robert P. Casey Jr.

United States Senator for Pennsylvania

Casey Introduces Bipartisan Bill to Help Develop Treatments for Rare DiseasesThursday, March 17, 2011

WASHINGTON, DC— U.S. Senator Bob Casey (D-PA) today introduced the Creating Hope Act of

2011, a bipartisan bill that would encourage the development of new treatments for rare and

neglected diseases that disproportionately affect children. The bill, which also has broad support

among the medical community, patient advocates and biopharmaceutical companies, would

strengthen a cost-neutral FDA program giving biopharmaceutical companies an incentive to develop

treatments for rare diseases that are often less profitable than treatments for more common medical

conditions.

“Millions of Americans are affected by rare diseases and neglected conditions for which there is

currently no hope because there is no treatment,” said Senator Casey. “The Creating Hope Act

brings light where there is now only darkness by providing an incentive, at no cost to taxpayers, to

develop treatments for these illnesses. The broad support for this legislation speaks to the need to

solve this problem.”

The Creating Hope Act is cosponsored by Senators Scott Brown (R-MA), Sherrod Brown (D-OH), Al

Franken (D-MN) and Johnny Isakson (R-GA).

Rare diseases, such as pediatric cancers, and neglected tropical diseases, such as malaria, affect

significant numbers of Americans and people around the globe. More than 20 million Americans

have a rare disease, according to the National Organization for Rare Disorders. An estimated one

billion people worldwide suffer from a neglected tropical disease according to the World Health

Organization, and children are most frequently and profoundly affected by these conditions.

“I applaud Senator Casey’s leadership in introducing the Creating Hope Act,” said Nancy Goodman,

Executive Director of Kids v. Cancer. “I want to ensure that one day, children like my son, Jacob,

who are diagnosed with brain cancer and other serious and rare diseases, will have drugs available

for safe and effective treatments.”

Peter C. Adamson, M.D., Chair of the Children’s Oncology Group at the Children’s Hospital of

Philadelphia, said: “I commend Senator Casey and his colleagues for introducing the Creating Hope

Act of 2011. As a pediatric oncologist who leads the Children’s Oncology Group, a nationwide team

of physicians, scientists, nurses and others dedicated to treating children with cancer, I know that

improving the outcome for children with cancer will require development of new, more effective

Robert P. Casey Jr. | United States Senator for Pennsylvania: Newsroom - ... http://casey.senate.gov/newsroom/press/release/?id=a8deb1ac-6ffd-424b...

1 of 3 7/15/2011 11:37 AM

APPENDIX C GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 17

anti-cancer drugs. With cancer remaining the leading cause of disease related death in children in

the United States, the Creating Hope Act of 2011 will provide a critically important new way to help

engage scientists in the biopharmaceutical industry to help develop better medicines for the children

we care for.”

“Long a pioneer in pediatric medical research, Children’s Hospital of Pittsburgh of UPMC is

committed to seeking new and innovative therapies for the cure of childhood diseases and disability

– no matter how rare,’’ said David H. Perlmutter, MD, Physician-in-Chief and Scientific Director.

“Creating incentives for companies to invest in new treatments will help ensure our continued

advancement in providing the most exceptional medical care for the most vulnerable children.”

“Of the nearly one in 10 Americans with rare diseases, approximately two-thirds are children,” said

Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD).

“Many of these rare pediatric diseases are very serious and treatments are desperately needed. By

expanding priority review vouchers to include pediatric rare diseases, this legislation would

encourage the development of treatments for children with serious rare diseases.”

“Pennsylvania Bio thanks Senator Casey for his continued commitment to the life sciences industry

and the thousands of patients in the United States who suffer from rare diseases,” stated

Christopher P. Molineaux, President, Pennsylvania Bio. “With nearly 7,000 rare diseases, defined as

diseases affecting 200,000 or fewer Americans, few treatment options exist for these small patient

populations because it is often prohibitive for companies to enter the rare disease marketplace.

Pennsylvania Bio encourages members of the 112th Congress to follow Senator Casey’s lead and

take the necessary steps to support corporations who are conducting research into treatments for

these rare diseases, many of which affect children.”

Despite this significant unmet medical need, private companies seldom pursue new therapies for

tropical illnesses or rare diseases because it requires making an investment in products that will

likely not recoup the high costs associated with their research, development, marketing and

distribution. Developing products for children is particularly challenging because of the difficulties

associated with conducting clinical trials on this population.

Currently, pharmaceutical companies can receive a priority review voucher (PRV) if they develop

novel treatments for neglected tropical diseases, entitling the company to a priority six month review

of another new drug application that would otherwise be reviewed under the FDA’s standard ten

month review period. This shortened review time, which can lead to earlier market entry, is estimated

to be worth hundreds of millions of dollars.

The Creating Hope Act of 2011 will build on the PRV program to create a stronger incentive for

companies to invest in new treatments for rare diseases affecting children and neglected tropical

Robert P. Casey Jr. | United States Senator for Pennsylvania: Newsroom - ... http://casey.senate.gov/newsroom/press/release/?id=a8deb1ac-6ffd-424b...

2 of 3 7/15/2011 11:37 AM

APPENDIX C GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 18

diseases. This legislation will:

• Expand priority review vouchers to include treatments for pediatric rare diseases, so that

there is greater incentive to close the devastating treatment gap for kids.

• Close a loophole in current law to prevent companies from receiving a voucher for products

that they already market in other countries.

• Offer unlimited transferability of vouchers to create a more easily-traded asset.

• Provide greater certainty to sponsors by permitting them to seek a designation from FDA

before they submit their new drug application that the drug, if approved, will qualify for a voucher.

• Strengthen reporting and marketing requirements by requiring that the sponsor submit a

statement of good faith intent to market the eligible drug.

• Add Chagas disease, which is responsible for more deaths in Central and South America

than every other parasite-borne disease, to FDA’s list of neglected tropical diseases.

The following groups and businesses have endorsed the legislation: Aeras Global TB Vaccine

Foundation, Association of Pediatric Oncology Social Workers, American Society of Clinical

Oncology, American Society of Pediatric Hematology and Oncology, American Society for Tropical

Medicine and Hygiene (ASTMH), Bio Ventures for Global Health, Chai Lifeline, Children's Brain

Tumor Foundation, Children’s Hospital of Philadelphia, Children’s Hospital of Pittsburgh of UPMC,

CureSearch, GlaxoSmithKline, Genzyme, Kids v Cancer, Leukemia & Lymphoma Society, The

National Association of Children’s Hospitals, The National Children's Cancer Society, National

Organization for Rare Disorders, Novartis, Medicines for Malaria Venture (MMV), Merck, Metronomix,

Sarcoma Foundation of America, Pennsylvania BIO, Shire, CSL Behring, TB Alliance.

###

Robert P. Casey Jr. | United States Senator for Pennsylvania: Newsroom - ... http://casey.senate.gov/newsroom/press/release/?id=a8deb1ac-6ffd-424b...

3 of 3 7/15/2011 11:37 AM

APPENDIX D GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 19

For Immediate Release Contact: Bill Mashek March 8, 2011 202.354.8275

bmashek@pstrategies.com

America Invents Act Boosts Innovation and Jobs, Strengthens Patent System

Coalition Appreciates Bipartisan Support in Senate and Looks Forward to House Action

Washington, D.C. – After the U.S. Senate’s overwhelming vote this evening to adopt S. 23, The America Invents Act, Gary Griswold of the Coalition for 21st Century Patent Reform released the following statement: “With the approval of S. 23, The America Invents Act, the U.S. Senate has moved the nation forward in promoting innovation, protecting inventions and enhancing the operations of the U.S. Patent and Trademark Office. The bipartisan leadership of Chairman Leahy, Senators Grassley, Hatch, Kyl, Klobuchar and others, as well as the efforts of the Administration, were instrumental in securing such a strong vote for helping America’s inventors. As amended, S. 23 answers the call of American innovators because this bill will give the USPTO the tools and funding it needs to process patents in a more effective and efficient way. Accordingly, this legislation will make our nation more competitive in the global marketplace and set in place rules that will benefit the next generation of inventors. It is clear that the 112th Congress wants to promote innovation and create jobs; adoption of S. 23 is a major step forward in achieving these goals. It is very encouraging that the members of the House and Senate have been in discussions on the issue and that the House Judiciary Committee is actively moving ahead with its consideration of patent reform. Our Coalition looks forward to continuing to work with members of the Senate and the House to produce fair and balanced patent reform legislation.”

-- 30 --

The Coalition has approximately 50 members from 18 diverse industry sectors and includes many of the nation’s leading manufacturers and researchers. The coalition’s steering committee includes 3M, Caterpillar, General Electric, Johnson & Johnson, Eli Lilly and Procter & Gamble. The Coalition has members in a variety of industry sectors including: Aerospace and Defense, Chemical, Computers, Diversified Financials, Diversified Technology, Energy, Food Production, Forest & Paper Products, Health Care, Household & Personal Products, Industrial Equipment, Medical Equipment & Devices, Network & Communications, Payroll Services, Pharmaceutical, Biotechnology, Semiconductors & Electronic Components, and Transportation Equipment. Visit http://www.patentsmatter.com for more information.

APPENDIX E GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 20

Email address:

For Immediate Release Contact: Bill MashekApril 2, 2009 202.354.8275 bmashek@pstrategies.com

Coalition Supports Patent Reform LegislationAdopted in Senate Judiciary Committee

Bill Will Strengthen America's Patent System, Stimulate Invention andCreate Jobs

Washington, D.C. — The Chairman of the Coalition for 21st Century Patent Reform,Gary Griswold, released the following statement after the Senate JudiciaryCommittee adopted S. 515, The Patent Reform Act of 2009, by a 15-4 vote. As thebill moves to the Senate floor, the Coalition will continue to work in support of theeffort to improve the U.S. patent system.

"For more than six years, the Congress has worked on comprehensive patent reformlegislation. Today's strong vote by the Senate Judiciary Committee is an importantand meaningful step toward needed reform. The compromise package offered byChairman Leahy, Senator Specter, Senator Feinstein and other Senators had ourCoalition's strong support. As the patent reform bill proceeds through the legislativeprocess, we will continue to work with other Members of Congress to make furthertechnical changes which will facilitate the bill moving toward enactment.

Our Coalition appreciates and recognizes the focus and hard work by Senators andtheir staff over the past several weeks that led to the reporting of the bill by theCommittee. The compromise package, together with the other critical provisions ofthe bill, should improve the U.S. patent system.

With today's vote, the 111th Congress has set a course that will foster Americaninnovation and employment by ensuring the patent system is fair, balanced andpromotes research and innovation."

-- 30 --

The coalition has 50 members from 18 diverse industry sectors and includes many ofthe nation's leading manufacturers and researchers. The coalition's steeringcommittee includes 3M, Caterpillar, General Electric, Johnson & Johnson, Eli Lilly andProcter & Gamble. The coalition has members in a variety of industry sectorsincluding: Aerospace and Defense, Chemical, Computers, Diversified Financials,Diversified Technology, Energy, Food Production, Forest & Paper Products, HealthCare, Household & Personal Products, Industrial Equipment, Medical Equipment &Devices, Network & Communications, Payroll Services, Pharmaceutical,Biotechnology, Semiconductors & Electronic Components, and TransportationEquipment.

Download as PDF

September 16, 2011Leahy/Smith AmericaInvents Act PositionsInventors to “Win theFuture” (pdf)

September 8, 2011Senate Vote SendsLeahy/Smith AmericaInvents Act to White House(pdf)

August 14, 2011How to Encourage AmericanInnovation

June 23, 2011Coalition Praises HouseApproval of Leahy/SmithAmerica Invents Act (pdf)

June 21, 2011The Coalition for 21stCentury Patent Reformreaffirms its support formoving H.R. 1249. (pdf)

Home | About Us | Know the Issue | Press Room | Join Us | Member Login | Contact Us

© 2010 The Coalition for 21st Century Patent Reform

Patents Matter - The Coalition for 21st Century Patent Reform http://patentsmatter.com/press/20090402_support_statement.htm

1 of 1 5/2/2012 4:31 PM